Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-180-1 | CAS number: 66170-10-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Bacterial reverse mutation assay (Ames-Test):
In a reverse gene mutation assay in bacteria (BASF AG, 1997), strains TA 1535, TA 1537, TA 98 and TA 100 of Salmonella typhimurium and Escherichia coli WP2 uvr A were exposed to Sodium ascorbyl phosphate (85.4%) at concentrations of 0; 24; 120; 600; 3,000 and 6,000 µg/plate in the presence and absence of mammalian metabolic activation (plate co-incubation and pre-incubation).
Sodium ascorbyl phosphate was tested up to cytotoxic concentrations (6,000 µg/plate). The positive controls induced appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.
This study satisfies the requirement for Test Guideline EU B1.13/14 and OECD 471/472 for in vitro mutagenicity (bacterial reverse gene mutation) data.
Chromosome aberation test:
In a mammalian cell cytogenetics assay (Chromosome aberration) (BASF AG, 1998), V79 cell cultures were exposed to Sodium ascorbyl phosphate (85.4 %) dissolved in water at concentrations of 0, 500, 2000, 3800 µg/ml, with and/or without metabolic activation (S9 mix).
Sodium ascorbyl phosphate was tested (up to cytotoxic and limit concentration). No test article precipitation and no influence of the test article on the pH value or osmolarity was observed. In both independent experiments (plate incorporation (4 h) and pre-incubation test (18 h, 28 h)), neither a significant nor a biologically relevant increase in the number of cells carrying structural chromosomal aberrations was observed after treatment with the test article. In addition, no increase in the frequencies of polyploid metaphases was found after treatment with the test article as compared to the frequencies of the controls. Positive controls induced the appropriate response. There was no evidence or a concentration related positive response of Chromosome aberration induced over background.
This study satisfies the requirement for Test Guidelines (EU-method B.10 and OECD 473) for in vitro cytogenetic mutagenicity data.
Mouse Lymphoma assay (read across from ascorbic acid):
In a mammalian cell gene mutation assay (TK locus, Amacher 1991), mouse lymphoma L5178Y cells cultured in vitro were exposed to ascorbic acid (99.9 %, dissolved in saline 1%) up to a concentration of 4 mM (704 µg/mL) in the absence of mammalian metabolic activation.
Ascorbic acid was tested up to cytotoxic concentrations. Replicate experiments with pure ascorbic acid in medium resulted in cytotoxicity at ascorbic concentrations greater than 1.5 mM ca. 265 µg/mL), but no reproducible dose-dependent increase in mutant frequencies over background levels were seen. The positive controls induce the appropriate response.There was no evidence of induced mutant colonies over background.
In vivo bone marrow micronucleous assay (read across from ascorbic acid):
In a CD-1 mouse bone marrow micronucleous assay (Tsuchimoto, 1981), (2 animals/sex/dose) were treated i.p. with ascorbic acid at doses of 0, 80, 160, 320 mg/kg bw. Bone marrow cells were harvested at 6 hrs post-treatment. The vehicle was DMSO. The substance was administered twice, 24 hrs apart.
There was not a significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time. This study was not performed according to actual OECD or EU guideline but is well documented and considered scientificaly valid to evaluate the mutagenic potential of the test item in vivo.
Short description of key information:
One bacterial reverse mutation assay (Ames test) and a Chromosome aberration test with the test substance Sodium ascorbyl phosphate showed no mutagenic effects up to limit concentrations. No mouse lymhoma or HPRT test is available for Sodium ascorbyl phosphate.
No further studies with Sodium ascorbyl phosphate are available, but the parent compound ascobic acid was tested in a mouse lymphoma assay without metabolic activation and an in vivo bone marrow micronucleous assay demonstrating no mutagenic effects of ascorbic acid and are confirming the findings obtained with Sodium ascorbyl phosphate directly.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the results (negative Ames test, negative chromosome aberration test, negative mouse lymphoma assay - read across, negative in vivo bone marrow micronucleous assay - read across) Sodium ascorbyl phosphate is not classified mutagenic according to EU Directive 67/548/EC amended and repealed by EU Regulation No.1272/2008 and CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.